PTJ
SGMO

Paul Tudor Jones’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Paul Tudor Jones’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-363,490
Closed -$315K – 3458
2024
Q3 		$315K Hold
363,490
– – ﹤0.01% 2294
2024
Q2 		$130K Hold
363,490
– – ﹤0.01% 2192
2024
Q1 		$244K Hold
363,490
– – ﹤0.01% 1946
2023
Q4 		$197K Hold
363,490
– – ﹤0.01% 2208
2023
Q3 		$218K Hold
363,490
– – ﹤0.01% 2051
2023
Q2 		$473K Hold
363,490
– – 0.01% 1738
2023
Q1 		$640K Sell
363,490
-11,648
-3% -$33.2K 0.01% 1472
2022
Q4 		$1.18M Buy
375,138
+343,882
+1,100% +$1.33M 0.02% 995
2022
Q3 		$153K Sell
31,256
-113,059
-78% -$581K ﹤0.01% 2122
2022
Q2 		$597K Buy
144,315
+99,736
+224% +$431K 0.02% 1183
2022
Q1 		$259K Sell
44,579
-117,262
-72% -$697K 0.01% 1635
2021
Q4 		$1.21M Buy
161,841
+80,559
+99% +$700K 0.02% 896
2021
Q3 		$732K Buy
+81,282
New +$803K 0.01% 1382
2020
Q4 		– Sell
-94,667
Closed -$895K – 1596
2020
Q3 		$895K Buy
94,667
+27,094
+40% +$293K 0.04% 598
2020
Q2 		$605K Buy
+67,573
New +$627K 0.03% 662
2019
Q1 		– Sell
-14,819
Closed -$170K – 1252
2018
Q4 		$170K Buy
+14,819
New +$184K ﹤0.01% 887
2018
Q1 		– Sell
-54,864
Closed -$900K – 1212
2017
Q4 		$900K Buy
54,864
+23,855
+77% +$355K 0.02% 387
2017
Q3 		$465K Buy
31,009
+4,502
+17% +$49.8K 0.01% 665
2017
Q2 		$233K Buy
+26,507
New +$170K 0.01% 840
2017
Q1 		– Sell
-65,800
Closed -$201K – 1532
2016
Q4 		$201K Buy
+65,800
New +$240K 0.01% 1226
2015
Q1 		– Sell
-17,511
Closed -$266K – 1598
2014
Q4 		$266K Buy
+17,511
New +$213K 0.01% 1109
2013
Q4 		– Sell
-13,600
Closed -$143K – 1345
2013
Q3 		$143K Sell
13,600
-3,600
-21% -$35.8K 0.01% 762
2013
Q2 		$134K Buy
+17,200
New +$150K 0.01% 754

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Paul Tudor Jones's SGMO Position: Q4 2024 in Review

Paul Tudor Jones sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2024, closing a stake of 363,490 shares — an estimated $315K sold.

Paul Tudor Jones first reported a position in SGMO in Q2 2013 and held it in 23 quarters. The position peaked at $1.21M in Q4 2021. 128 funds tracked by Wall St. Rank hold SGMO as of Q4 2024.

  • Paul Tudor Jones reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2024 after selling out during the quarter.
  • Paul Tudor Jones sold 363,490 SANGAMO THERAPEUTICS INC shares in Q4 2024, an estimated $315K.
  • Paul Tudor Jones first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 23 quarters.
  • Paul Tudor Jones's SANGAMO THERAPEUTICS INC position peaked at $1.21M in Q4 2021.
  • 128 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2024.

Based on Tudor Investment Corp's 13F filing for Q4 2024, filed 14 Feb 2025.